You are currently viewing a new version of our website. To view the old version click .

Journal of Molecular Pathology, Volume 3, Issue 1

March 2022 - 6 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (6)

  • Feature Paper
  • Article
  • Open Access
4,754 Views
15 Pages

Evaluation of the TruSight Tumor 170 Assay and Its Value in Clinical Diagnostics

  • Carina Heydt,
  • Roberto Pappesch,
  • Katrin Stecker,
  • Martin März and
  • Sabine Merkelbach-Bruse

5 February 2022

Background: Parallel sequencing technologies have become integrated into clinical practice. This study evaluated the TruSight Tumor 170 assay for the simultaneous detection of somatic gene mutations (SNPs and indels), gene fusions and CNVs, and its i...

  • Article
  • Open Access
5 Citations
3,810 Views
14 Pages

21 January 2022

Background: We aimed at obtaining more information on the structure of fecal calprotectin (CP) as a basis for establishing improved quantitative assays and detection of Neutrophil Extracellular Traps (NETs) in stools. Commercial fecal CP assays produ...

  • Review
  • Open Access
4 Citations
5,217 Views
14 Pages

Molecular Testing and Treatment Strategies in RET-Rearranged NSCLC Patients: Stay on Target to Look Forward

  • Maria Lucia Reale,
  • Valentina Bertaglia,
  • Angela Listì,
  • Silvia Novello and
  • Francesco Passiglia

18 January 2022

RET alterations are recognized as key oncogenic drivers in different cancer types, including non-small cell lung cancer (NSCLC). Multikinase inhibitors (MKIs) with anti-RET activities resulted in variable efficacy with significant toxicities because...

  • Brief Report
  • Open Access
2 Citations
3,675 Views
9 Pages

Tissue Microarray from Cell Block Material (cbTMA)—An Additional Shot for Cytology in the Predictive Pathology Era: The PD-L1 Experience

  • Antonino Iaccarino,
  • Gennaro Acanfora,
  • Pasquale Pisapia,
  • Umberto Malapelle,
  • Claudio Bellevicine,
  • Giancarlo Troncone and
  • Elena Vigliar

12 January 2022

Generally, predictive biomarker tests are clinically validated on histological formalin-fixed, paraffin-embedded (FFPE) samples. In addition to FFPE samples, cytological samples have also emerged as a useful approach to detect predictive biomarkers....

  • Review
  • Open Access
4 Citations
5,046 Views
14 Pages

The Multifaceted Profile of Thyroid Disease in the Background of DICER1 Germline and Somatic Mutations: Then, Now and Future Perspectives

  • Sule Canberk,
  • Marcelo Correia,
  • Ana Rita Lima,
  • Massimo Bongiovanni,
  • Manuel Sobrinho-Simões,
  • Paula Soares and
  • Valdemar Máximo

11 January 2022

DICER1 protein is a member of the ribonuclease (RNAse) III family with a key role in the biogenesis of microRNAs (miRNA) and in microRNA processing, potentially affecting gene regulation at the post-transcriptional level. The role of DICER1 and its r...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
J. Mol. Pathol. - ISSN 2673-5261